Hypothermia in Acute Ischemic Stroke: Surface versus Endovascular cooling "HAIS-SE"

Recruiting

Phase N/A Results

Summary of Purpose

To evaluate feasibility, tolerability and safety of surface cooling (CSZ Blanketrol III) versus endovascular cooling (Zoll Thermogard XP) in awake patients with acute ischemic stroke plus acute stroke treatment including thrombolysis.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 December 2010.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • none

Trial Design

Prospective, open, randomized, controlled single-centre study (n=60).

Contacts

  • Center of clinical Neurosciences Heidelberg University INF 400 69120 Heidelberg Germany

    sven.poli@med.uni-heidelberg.de